ResMed Inc. (LON:0KW4)

Market Cap	29.84B
Revenue (ttm)	3.76B
Net Income (ttm)	1.02B
Shares Out	n/a
EPS (ttm)	6.94
PE Ratio	29.19
Forward PE	25.23
Dividend	1.67 (0.59%)
Ex-Dividend Date	Aug 14, 2025

Volume	101
Average Volume	129
Open	284.73
Previous Close	285.68
Day's Range	279.97 - 286.84
52-Week Range	199.71 - 297.98
Beta	0.77
RSI	42.01
Earnings Date	Jul 31, 2025

About ResMed

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1989
• Employees: 10,600
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0KW4

Financial Performance

In 2025, ResMed's revenue was $5.15 billion, an increase of 9.84% compared to the previous year's $4.69 billion. Earnings were $1.40 billion, an increase of 37.20%.

Financial numbers in USD